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Abstract
Retroviral vectors are widely used in gene therapy to introduce therapeutic genes into patients’ cells, since, once delivered
to the nucleus, the genes of interest are stably inserted (integrated) into the target cell genome. There is now compelling
evidence that integration of retroviral vectors follows non-random patterns in mammalian genome, with a preference for
active genes and regulatory regions. In particular, Moloney Leukemia Virus (MLV)–derived vectors show a tendency to
integrate in the proximity of the transcription start site (TSS) of genes, occasionally resulting in the deregulation of gene
expression and, where proto-oncogenes are targeted, in tumor initiation. This has drawn the attention of the scientific
community to the molecular determinants of the retroviral integration process as well as to statistical methods to evaluate
the genome-wide distribution of integration sites. In recent approaches, the observed distribution of MLV integration
distances (IDs) from the TSS of the nearest gene is assumed to be non-random by empirical comparison with a random
distribution generated by computational simulation procedures. To provide a statistical procedure to test the randomness
of the retroviral insertion pattern, we propose a probability model (Beta distribution) based on IDs between two
consecutive genes. We apply the procedure to a set of 595 unique MLV insertion sites retrieved from human hematopoietic
stem/progenitor cells. The statistical goodness of fit test shows the suitability of this distribution to the observed data. Our
statistical analysis confirms the preference of MLV-based vectors to integrate in promoter-proximal regions.
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Introduction
The transfer of a therapeutic gene into somatic cells (gene
therapy) is a promising medical approach for the management of
many inherited and acquired diseases. Among several systems
developed for gene delivery, replication-defective viral vectors
derived from retroviruses are the most widely used. In fact, after
infecting a target cell, retroviral vectors deliver the therapeutic
gene directly to the cell nucleus and stably insert it into the host
cell genome; the process is commonly referred to as ‘‘integration’’.
It has been observed that retroviral vectors integrating in the
proximity of the transcription start site (TSS) of host genes may
enhance or disrupt normal transcription [1], occasionally favouring
tumourinitiation[2,3] (insertionaloncogenesis).Such genotoxicrisk
represents a major hurdle to the safety of gene therapy and requires
sensitive pre-clinical assays for insertional mutagenesis [4,5].
Understanding location preferences of retroviruses becomes
crucial in evaluating both the safety profile of a therapeutic vector
as well as the integration process per se, which is still far from being
completely understood.
Just few years ago, retrovirus integration was believed to be
random, and the chance of accidentally activating a gene was
considered remote. Recent studies based on cellular and animal
models (reviewed in [6]) reported empirical evidence of preference
for certain retroviral vectors, i.e. those deriving from Moloney
Murine Leukemia Virus (MLV), to integrate near the start of
transcriptional units, whereasothers (likeSimianImmunodeficiency
Virus (SIV)– and Human Immunodeficiency Virus (HIV)–based
vectors) did not show the same tendency. A representative example
is given in Figure 1 (see [7]). In this case, the variable of interest to
investigate integration preferences is the integration distance (ID)
from the TSS of the nearest gene. In statistical terms, this is a signed
distance function [8,9], since it assumes negative or positive values
according to the position of integration site with respect to the gene
(upstream and downstream, respectively). The distribution of MLV
IDs from the TSS shows a bell shape [10]. Here we remark that
‘‘bell-like’’ shape does not necessarily mean a ‘‘Gaussian’’
distribution. Indeed, other distributions (e.g., Cauchy distribution,
Laplace distribution) may show a ‘‘bell-shape’’ similar to that
observed in Figure 1. This is considered by the authors as sufficient
evidenceofanon-random pattern when comparedtothealmost flat
distributionof65,000computer-generatedrandominsertionsites.A
crucial issue for mathematical biologists is to provide an analytic
approach for the assessment of such non-randomness [11].
In this paper, we first show that a bell-shape distribution is not
necessarily evidence of non-randomness. Then we introduce a new
distance measure based on a normalization of the conventional
ID. This new variable is assumed to follow a Beta distribution, thus
allowing us to build a direct testing procedure for the non-random
integration hypothesis. Applied to real experimental data, the
estimated parameters provide a statistical measure confirming
retroviral integration preferences for the proximity of TSSs.
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Definitions
Each retroviral integration is defined by its nucleotide position
on the chromosome (UCSC Genome Browser, human genome
assembly March 2006, hg18 release, http://genome.ucsc.edu/).
Integration-proximal genes are annotated according to UCSC
RefSeq Genes category. For each insertion site (IS), the following
definitions are uniquely given:
N nearest gene: nearest 39 or 59 end of a gene
N nearest upstream TSS
N nearest downstream TSS
These definitions are applied to integrations landing within
transcriptional units (intragenic) as well as to insertions mapping
between two genes (intergenic). Integration distances from the
nearest gene TSS and from the nearest 59 and 39 TSSs are then
computed. IDs assume positive or negative values when the
insertion nucleotide is located downstream or upstream of the
TSS, respectively. Figure 2 provides a schematic representation of
one intergenic integration from our dataset with the nearest
transcriptional units. The IDs from the TSS relevant to this paper
are shown.
Modelling Integration Distance Distribution
Let X be the random variable (r.v.) describing the integration
position. We next address the problem of testing the hypothesis of
randomness of X over the genome with respect to the TSS. In
statistical terms, this is equivalent to testing that the null hypothesis
H0: X is distributed uniformly over the whole genome. The
alternative hypothesis is H1: X distribution is influenced by the
TSS.
Starting from a common annotation criteria [2,7,12,13], we
focus on ID from the TSS of the nearest 39 or 59 end of a gene
(which might differ from the ID from the nearest TSS). We call
this distance Y(X) defined as a function of X:





where Wj(X) represents the TSS position of the nearest annotated
gene gk.
Let us now suppose random integration, that is X is uniformly
distributed over the genome. Despite this, it can be seen that Y
might well be non-uniformly distributed. This is shown in Figure 3,
where 1,250,000 integrations are generated from a Uniform
distribution over the support [1, ,3610
9 bases] and Y(X) are
computed with respect to real TSSs and gene length distributions
(Text S1, Remark 1). We can observe a bell-shaped distribution
Figure 1. Distribution of Moloney Leukemia Virus (MLV) and Simian Immunodeficiency Virus (SIV) integration sites centered on
transcription start sites of the nearest gene. The empirical comparison between simulated (dotted line) and observed distribution leads the
authors to conclude in favour of non-randomness of retroviral integration.
doi:10.1371/journal.pcbi.1000144.g001
Author Summary
Understanding how retroviral vectors (such as Moloney
Leukemia Virus–based vectors) integrate in the human
genome became a major safety issue in the field of gene
therapy, since a concrete risk of developing tumors
associated with the integration process was assessed in
the clinical setting. Moloney Leukemia Virus–based vectors
are apparently characterized by a non-random integration
pattern, with a preference for the vicinities of active gene
transcription start sites. We approach the problem of non-
random retroviral integration from a probabilistic point of
view. We model a normalized integration distance from
the transcription start site of the nearest upstream or
downstream gene. From this model, we derive a simple
and straightforward testing procedure to estimate how the
transcription start site of a given gene may or may not
attract integration events. Our approach overcomes the
issues of different gene length, gene orientation, and gene
density, which are often critical in analyzing integration
distances from transcription start sites. The approach is
tested on real experimental data retrieved from human
hematopoietic stem/progenitor cells.
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given the uneven distribution of gene lengths and distances in the
human genome. As a result, short IDs are more likely to be
observed, whereas large IDs can only be observed for long genes
and/or long intergenic distances; thus, they are less probable (see
Figure 4). In fact, it can be proven that the exact distribution of Y is
a mixture of Uniform distributions having support over the
(signed) distances between two consecutive start sites. Thus,
different gene lengths and gene orientations per se produce the bell-
shaped ID distribution no matter what the integration preferences
are.
We next build a new testing procedure for non-randomness. We
start by normalizing the r.v. Y(X) (for simplicity hereafter denoted
by Y). We define the IDs from the nearest downstream (YD) and
upstream (YU) TSSs as:
YD~ X{WjX ðÞ


















which describes the ID as a proportion of the total distance
between the start sites of two consecutive genes. Notice that Y
*
now becomes independent of gene length, gene orientation, and gene
Figure 2. Example of integration distance calculation for one integration site mapped on Chromosome 4 (CB-RV51 insertion site in
[20] dataset). Notice that in this particular case the transcription start site (TSS) of the nearest gene coincides with the nearest downstream (39) TSS.
doi:10.1371/journal.pcbi.1000144.g002
Figure 3. Distribution of 1,250,000 integration distances (kb) from the transcription start site (TSS) of the nearest gene (Y)
randomly generated from a Uniform distribution. The solid line is the kernel density estimate plotted within a 630 kb window for a better
graphical visualization of the ’’bell-shape’’ curve.
doi:10.1371/journal.pcbi.1000144.g003
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*#1. In statistical terms, we assume as a
convenient distribution for Y
* the Beta distribution, which is one of
the most widely used in clinical, biological, and genetic settings
(Bayesian frameworks [14,15]). In fact, Beta distribution models
events are constrained to take value within a finite interval (Text
S1, Remark 2). This includes as a particular case the Uniform
distribution on support [0,1], which coincides with our null
hypothesis of random integration. For these reasons, the Beta
distribution looks very suitable to describe, within the same
parametric family, the integration preferences. This distribution
family depends on two free parameters, p and q. The probability
density function is given by:











*#1 and 0 otherwise, p.0, q.0.
The main aim of the modelling is the estimation of the
parameters p and q. The null hypothesis ‘‘X is distributed
uniformly over the whole genome’’ corresponds to ‘‘Y
* is uniformly
distributed in [0,1]’’, that is equivalent to a Beta distribution with
both p and q equal to one. The parameter estimates have also a
practical interpretation: different values of p and q reflect different
integration preferences as in Figure 5. This can also be easily
visualized: a ‘‘U’’ shape in the distribution of Y
* indicates that
integrations land close to a TSS with higher probability (TSS
attracts integrations). This occurs when both the beta parameters p
and q are less than 1. On the contrary, p and q greater than 1
means that integration around a TSS is disfavoured. A straight line
for Y
* distribution (p=q=1) indicates that integrations are
randomly located with respect to a TSS.
In summary, we can now redefine the null hypothesis of random
distribution of IDs in terms of values of the parameters (p,q), since
the uniform distribution is a particular case of Beta, that is:
Hypothesis system
H0 : p~q~1
H1 : p=1 or q=1

ð5Þ
To test the null hypothesis in Equation 5, we use Maximum
Likelihood Estimators (MLEs; see Text S1, Remark 4) for the joint
estimate of the parameters (p,q).
Method-of-Moments Estimates (MMEs) are also provided since
it is well known that MMEs can be quickly and easily calculated
(see Text S1, Remark 3), whereas the MLEs often involve more
complex procedures (see Text S1, Remark 4). Typically, values for
MLEs are obtained numerically by means of the Newton-Raphson
method applied to the log-likelihood function (Figure 6). For more
detailed comparison between the MMEs and MLEs for the
parameters of a Beta (p,q) distribution, see [16,17].
Comparison between observed and fitted IDs distribution to assess
goodness of fit is performed by the Kolmogorov-Smirnov test.
Confidence intervals of 95% are built on Bootstrap 50,000
replications [18]. We consider as anoverall significance level a=0.05.
Statistical analyses were performed with R-statistical software
(ver. 2.6.1) [19].
Results
We apply the testing procedure described in Equation 5 to a
real experimental dataset. This includes 595 integrations retrieved
from human hematopoietic stem/progenitor cells (CD34
+ popu-
Figure 4. Integration distance (ID) from the nearest gene transcription start site (TSS). In this picture, six hypothetical genes with different
length and orientation (blue arrows) are scattered along a chromosome (x-axis). The purple piecewise linear function represents the distance from
the TSS of the nearest gene. This function has discontinuities exactly in the middle of the intervals between two consecutive genes. Even assuming a
series of random integrations in this setting, we obtain a distribution of distances from TSSs (projected on the y-axis, gray plot) which is a mixture of
Uniform distributions. As a consequence, the bell-shape curve is observed. Notice that the ID distribution is asymmetric around zero, since gene
orientations and gene lengths determine which is the TSS to be considered in computing the distances (a symmetric distribution would be observed
plotting the distance from the nearest TSS instead of the nearest gene TSS, data not shown).
doi:10.1371/journal.pcbi.1000144.g004
Retroviral Integration in the Human Genome
PLoS Computational Biology | www.ploscompbiol.org 4 August 2008 | Volume 4 | Issue 8 | e1000144lation) isolated from umbilical cord blood and infected in vitro
with MLV-based retroviral vectors (RV and SIN-RV datasets in
[20]). Integration analysis was performed 2 weeks after transduc-
tion, extracting genomic DNA from cells that underwent a
maximum of 6 cell doublings (see [20] for more details about data
and experimental procedures). The short-term culture period is a
fundamental requirement to exclude a clonal selection effect,
which indeed can occur in long-term culture or in vivo. This makes
the dataset very suitable for investigating the integration preferences
persewithout confounding.The observeddistributionoftheIDfrom
the TSS of the nearest genes is in accordance to the literature.
In Figure 7, the observed distribution and fitted Beta distribution
are plotted together. Goodness of fit for Beta distribution is assessed
Figure 5. Beta probability distribution functions for different parameter combinations. Solid black line represents the case of Uniform
distribution (p=q=1). Other curves are all consistent with the alternative hypothesis in H1: p?1o rq?1.
doi:10.1371/journal.pcbi.1000144.g005
Figure 6. Loglikelihood function related to the distribution of
Y
* observed in human hematopoietic/stem progenitor cells
showing the Maximum Likelihood Estimator (MLE) for the
parameters p and q.
doi:10.1371/journal.pcbi.1000144.g006
Figure 7. Comparison between the observed Y
* distribution
and the fitted distributions of Method of Moments Estimators
(MMEs, red dashed line) and Maximum Likelihood Estimators
(MLEs, blue dashed line). Goodness of fit was assessed by
Kolmogorov Smirnov test (MME p-value=0.909, MLE p-value=0.8012).
doi:10.1371/journal.pcbi.1000144.g007
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shown by a graphical investigation in Figure 7 suggests some
evidence against random integration hypothesis. According to the
hypothesis system, we estimate integration preferences by MMEs
obtaining separate confidence intervals for p ˜ and q ˜ and by MLEs (p ˆ
and q ˆ) to obtain p-values for the joint test in Equation 5. Estimation
results are reported in Table 1. Parameter estimates are always less
than 1 with an associated p-value,0.0001, leading to rejection of the
hypothesis of uniformity of Y
* in favour of the hypothesis that the
TSS ‘‘attracts’’ integrations.
Discussion
Tumorigenesis induced by slow-transforming retroviruses occurs
by insertional activation or deregulation of cellular proto-oncogenes
by viral LTRs. Recent observations from gene therapy trials and
pre-clinical models pointed out that MLV-derived retroviral vectors
still retain this transforming ability, even if at a lower extent. Such
genotoxic risk is augmented by MLV tendency to integrate near the
TSS of host genes, where LTR transactivation can be more
effective. For safety reasons, it becomes therefore crucial to
understand the basis for retroviral integration site selection.
The goal of this paper is to provide a simple statistical tool to test
whether integration data are distributed randomly over mamma-
lian genome, in particular with respect to the transcription start
site of genes surrounding integration events.
Our starting point is that integration distances generated in silico
from a Uniform distributionshow a bell-like shape as a consequence
of different gene lengths and intergenic distances over the genome.
Thus, when such shape is observed, it cannot automatically be
interpreted as evidence of non-random integration distribution.
We propose a new method based on modelling the probability
distribution function of IDs between two consecutive start sites. The
normalizeddistanceisassumed to follow a Beta distribution,bothfor
statistical tractability and for suitability to the biomedical framework.
This method differs from the commonly used simulation techniques
to the extent that it models fully parametrically the ID distribution,
with no need for a computationally demanding procedure. A big
advantage of the proposed approach with respect to simulation
procedures derives from the natural interpretation of Beta
parameters. As seen in Figure 5, we can investigate how the TSS
influences integration site selection: both ‘‘TSS attraction’’ (p and q
less than 1) and ‘‘TSS repulsion’’ (p and q greater than 1) can now be
tested. Notice that this information is not provided by the non-
parametric Kolmogorov-Smirnov test for homogeneity of distribu-
tions, which verifies only whether two distributions are different but
is not able to measure in which direction.
Estimation results derived from real experimental data show a
U shape of the Beta distribution with a higher probability assigned
to values in proximity of the TSS. Our statistical analysis confirms
(also in human hematopoietic stem/progenitor cells) the prefer-
ence of MLV-derived vectors to integrate in promoter-proximal
regions, suggesting that the viral integrating machinery interacts
preferentially with factors bound in the proximity of gene TSSs.
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